US Drug Approval A040905

Kalexate  Mar 30, 2009

2 approved drug products.
Kalexate
  • Ingredients: Sodium Polystyrene Sulfonate;
  • Dosage form: powder;
  • Route of administration: oral, rectal;
  • Strength: 15gm/bot;
  • Approval date: April 3, 2015;
  • Marketing status: prescription.
Kalexate
  • Ingredients: Sodium Polystyrene Sulfonate;
  • Dosage form: powder;
  • Route of administration: oral, rectal;
  • Strength: 454gm/bot;
  • Approval date: March 30, 2009;
  • Marketing status: prescription.

Parties

Applicants
Countries
US

JSON preview

Similar records

Title

Source:  FDA Last updated:  Jul 8, 2019

From the Orange Book, a publication of the U.S. Food and Drug Administration. This record may not reflect the most current and accurate biomedical/scientific data available from the FDA.